Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis

BACKGROUND: Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors.AIM:...

Full description

Saved in:
Bibliographic Details
Published inOpen access Macedonian journal of medical sciences Vol. 5; no. 2; pp. 160 - 166
Main Authors Hammam, Olfat, Aboushousha, Tarek, El-Hindawi, Ali, Khairy, Hosni, Khalil, Heba, Kamel, Amira, Akl, Maha, Abdel-Hady, Ahmed, Magdy, Mona, Badawy, Mohamed, El Kholy, Amr, Al Osili, Khalid, Kamel, Nora, Anis, Shady, El Leithy, Tarek
Format Journal Article
LanguageEnglish
Published Macedonia ID Design 2012/DOOEL Skopje 15.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BACKGROUND: Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors.AIM: We aimed at evaluating the expression of the FGFR3 protein and gene amplification in the urothelial cells of neoplastic and non-neoplastic urothelial lesions of the urinary bladder, and correlation with tumour grade, stage and associated bilharziasis.MATERIAL AND METHODS: One hundred and five different urinary bladder lesions were studied, including 15 cystitis cases (9 bilharzial and 6 non-bilharzial cystitides), 75 urothelial carcinoma cases (18 bilharzial associated and 57 non-bilharzial associated) and 15 squamous cell carcinoma associated with bilharziasis, beside 5 control cases. Data concerning age, sex, tumour grade, stage, and associated bilharziasis were obtained. Each case was studied for FGFR3 expression, and FISH technique was applied on forty malignant cases that show high protein expression.RESULTS: The highest incidence of cystitis was in the fourth decade while of bladder cancer was in the seventh decade. Tumour grade was correlated significantly with tumour stage. FGFR3 correlates significantly with tumour grade, stage and with a bilharzial infestation. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours.CONCLUSIONS: FGFR3 overexpression in malignant cases was significantly higher than in chronic cystitis. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours. FGFR3 may be further studied as a subject for target therapy of bladder cancer.
AbstractList Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors. We aimed at evaluating the expression of the FGFR3 protein and gene amplification in the urothelial cells of neoplastic and non-neoplastic urothelial lesions of the urinary bladder, and correlation with tumour grade, stage and associated bilharziasis. One hundred and five different urinary bladder lesions were studied, including 15 cystitis cases (9 bilharzial and 6 non-bilharzial cystitides), 75 urothelial carcinoma cases (18 bilharzial associated and 57 non-bilharzial associated) and 15 squamous cell carcinoma associated with bilharziasis, beside 5 control cases. Data concerning age, sex, tumour grade, stage, and associated bilharziasis were obtained. Each case was studied for FGFR3 expression, and FISH technique was applied on forty malignant cases that show high protein expression. The highest incidence of cystitis was in the fourth decade while of bladder cancer was in the seventh decade. Tumour grade was correlated significantly with tumour stage. FGFR3 correlates significantly with tumour grade, stage and with a bilharzial infestation. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours. FGFR3 overexpression in malignant cases was significantly higher than in chronic cystitis. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours. FGFR3 may be further studied as a subject for target therapy of bladder cancer.
BACKGROUND: Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors.AIM: We aimed at evaluating the expression of the FGFR3 protein and gene amplification in the urothelial cells of neoplastic and non-neoplastic urothelial lesions of the urinary bladder, and correlation with tumour grade, stage and associated bilharziasis.MATERIAL AND METHODS: One hundred and five different urinary bladder lesions were studied, including 15 cystitis cases (9 bilharzial and 6 non-bilharzial cystitides), 75 urothelial carcinoma cases (18 bilharzial associated and 57 non-bilharzial associated) and 15 squamous cell carcinoma associated with bilharziasis, beside 5 control cases. Data concerning age, sex, tumour grade, stage, and associated bilharziasis were obtained. Each case was studied for FGFR3 expression, and FISH technique was applied on forty malignant cases that show high protein expression.RESULTS: The highest incidence of cystitis was in the fourth decade while of bladder cancer was in the seventh decade. Tumour grade was correlated significantly with tumour stage. FGFR3 correlates significantly with tumour grade, stage and with a bilharzial infestation. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours.CONCLUSIONS: FGFR3 overexpression in malignant cases was significantly higher than in chronic cystitis. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours. FGFR3 may be further studied as a subject for target therapy of bladder cancer.
Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors.BACKGROUNDBladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors.We aimed at evaluating the expression of the FGFR3 protein and gene amplification in the urothelial cells of neoplastic and non-neoplastic urothelial lesions of the urinary bladder, and correlation with tumour grade, stage and associated bilharziasis.AIMWe aimed at evaluating the expression of the FGFR3 protein and gene amplification in the urothelial cells of neoplastic and non-neoplastic urothelial lesions of the urinary bladder, and correlation with tumour grade, stage and associated bilharziasis.One hundred and five different urinary bladder lesions were studied, including 15 cystitis cases (9 bilharzial and 6 non-bilharzial cystitides), 75 urothelial carcinoma cases (18 bilharzial associated and 57 non-bilharzial associated) and 15 squamous cell carcinoma associated with bilharziasis, beside 5 control cases. Data concerning age, sex, tumour grade, stage, and associated bilharziasis were obtained. Each case was studied for FGFR3 expression, and FISH technique was applied on forty malignant cases that show high protein expression.MATERIAL AND METHODSOne hundred and five different urinary bladder lesions were studied, including 15 cystitis cases (9 bilharzial and 6 non-bilharzial cystitides), 75 urothelial carcinoma cases (18 bilharzial associated and 57 non-bilharzial associated) and 15 squamous cell carcinoma associated with bilharziasis, beside 5 control cases. Data concerning age, sex, tumour grade, stage, and associated bilharziasis were obtained. Each case was studied for FGFR3 expression, and FISH technique was applied on forty malignant cases that show high protein expression.The highest incidence of cystitis was in the fourth decade while of bladder cancer was in the seventh decade. Tumour grade was correlated significantly with tumour stage. FGFR3 correlates significantly with tumour grade, stage and with a bilharzial infestation. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours.RESULTSThe highest incidence of cystitis was in the fourth decade while of bladder cancer was in the seventh decade. Tumour grade was correlated significantly with tumour stage. FGFR3 correlates significantly with tumour grade, stage and with a bilharzial infestation. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours.FGFR3 overexpression in malignant cases was significantly higher than in chronic cystitis. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours. FGFR3 may be further studied as a subject for target therapy of bladder cancer.CONCLUSIONSFGFR3 overexpression in malignant cases was significantly higher than in chronic cystitis. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours. FGFR3 may be further studied as a subject for target therapy of bladder cancer.
Author Khalil, Heba
Badawy, Mohamed
El Leithy, Tarek
Al Osili, Khalid
Kamel, Nora
El Kholy, Amr
Kamel, Amira
Abdel-Hady, Ahmed
Khairy, Hosni
Hammam, Olfat
Aboushousha, Tarek
Akl, Maha
Magdy, Mona
El-Hindawi, Ali
Anis, Shady
AuthorAffiliation 1 Theodor Bilharz Research Institute, Imbaba, Giza, Cairo, Egypt
2 Faculty of Medicine Cairo University, Cairo, Egypt
3 National Research Center5, El Doki, Giza, Egypt
AuthorAffiliation_xml – name: 2 Faculty of Medicine Cairo University, Cairo, Egypt
– name: 1 Theodor Bilharz Research Institute, Imbaba, Giza, Cairo, Egypt
– name: 3 National Research Center5, El Doki, Giza, Egypt
Author_xml – sequence: 1
  givenname: Olfat
  surname: Hammam
  fullname: Hammam, Olfat
– sequence: 2
  givenname: Tarek
  surname: Aboushousha
  fullname: Aboushousha, Tarek
– sequence: 3
  givenname: Ali
  surname: El-Hindawi
  fullname: El-Hindawi, Ali
– sequence: 4
  givenname: Hosni
  surname: Khairy
  fullname: Khairy, Hosni
– sequence: 5
  givenname: Heba
  surname: Khalil
  fullname: Khalil, Heba
– sequence: 6
  givenname: Amira
  surname: Kamel
  fullname: Kamel, Amira
– sequence: 7
  givenname: Maha
  surname: Akl
  fullname: Akl, Maha
– sequence: 8
  givenname: Ahmed
  surname: Abdel-Hady
  fullname: Abdel-Hady, Ahmed
– sequence: 9
  givenname: Mona
  surname: Magdy
  fullname: Magdy, Mona
– sequence: 10
  givenname: Mohamed
  surname: Badawy
  fullname: Badawy, Mohamed
– sequence: 11
  givenname: Amr
  surname: El Kholy
  fullname: El Kholy, Amr
– sequence: 12
  givenname: Khalid
  surname: Al Osili
  fullname: Al Osili, Khalid
– sequence: 13
  givenname: Nora
  surname: Kamel
  fullname: Kamel, Nora
– sequence: 14
  givenname: Shady
  surname: Anis
  fullname: Anis, Shady
– sequence: 15
  givenname: Tarek
  surname: El Leithy
  fullname: El Leithy, Tarek
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28507621$$D View this record in MEDLINE/PubMed
BookMark eNp1kcFvFCEUxompsbX27M1w9LJbYIYBLia16a4mm9hUeyYMvLE0DKww2-h_L-PWpm3SEyTv933v5fveooOYIiD0npJlI6U6TWa8HcuSESqWpJWv0BGVXCxUx_nBo_8hOinllhBCueooY2_QIZOciI7RIxQufm8zlOJTxGnAq_XqqsGXOU3gIzbR4TVEwGfjNvjBWzPNXJ1cZx9N_oM_B-McZLyB2aHMoysIe2xK-Lu98WVKJY3eFF_eodeDCQVO7t9jdL26-HH-ZbH5tv56frZZ2EZIuTCNawcQPRFM9a0gzEhHeKsGw8ApzqztqW0F7Y0SpgFHWSf73qnO2M7xdmiO0ae973bXj-AsxCmboLfZj_VonYzXTyfR3-if6U7zltVcRDX4eG-Q068dlEmPvlgIwURIu6KpVKolNURV0Q-Pdz0s-R9xBU73gM2plAzDA0KJnnvU-x713KOuPVYFf6awfvqXaT3Whxd1fwHXx6W9
CitedBy_id crossref_primary_10_3889_oamjms_2023_11372
crossref_primary_10_3390_cells10051201
crossref_primary_10_3892_ijo_2019_4763
crossref_primary_10_1007_s11033_023_08370_z
crossref_primary_10_1155_2020_8270810
Cites_doi 10.1158/1535-7163.MCT-12-1150
10.1111/his.12473
10.1593/neo.07178
10.1002/hep.25956
10.1007/s10552-007-9104-7
10.1002/cam4.262
10.1136/jclinpath-2015-202898
10.1016/j.febslet.2009.09.021
10.1016/j.jare.2013.06.007
10.1016/j.juro.2011.09.008
10.1002/path.4334
10.1002/path.2207
10.1097/00001648-200111000-00022
10.1002/ijc.23547
10.1155/2012/429213
10.1186/1756-9966-28-27
10.1016/j.canep.2010.05.003
10.1186/1750-9378-8-19
ContentType Journal Article
Copyright Copyright: © 2017 Olfat Hammam, Tarek Aboushousha, Ali El-Hindawi, Hosni Khairy, Heba Khalil, Amira Kamel, Maha Akl, Ahmed Abdel-Hady, Mona Magdy, Mohamed Badawy, Amr El Kholy, Khalid Al Osili, Nora Kamel, Shady Anis, Tarek El Leithy. 2017
Copyright_xml – notice: Copyright: © 2017 Olfat Hammam, Tarek Aboushousha, Ali El-Hindawi, Hosni Khairy, Heba Khalil, Amira Kamel, Maha Akl, Ahmed Abdel-Hady, Mona Magdy, Mohamed Badawy, Amr El Kholy, Khalid Al Osili, Nora Kamel, Shady Anis, Tarek El Leithy. 2017
DBID AAYXX
CITATION
NPM
7X8
5PM
DOI 10.3889/oamjms.2017.048
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1857-9655
EndPage 166
ExternalDocumentID PMC5420767
28507621
10_3889_oamjms_2017_048
Genre Journal Article
GroupedDBID 53G
AAYXX
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
CITATION
C~G
DYU
HYE
IPNFZ
KQ8
M48
M~E
OK1
PGMZT
RIG
RPM
SLJYH
GROUPED_DOAJ
NPM
7X8
5PM
ABFKT
ID FETCH-LOGICAL-c3788-a3d4fe7b0729b4702a8d0549fa2ed952ccb1c471ba97a3ed1268bbd96ac6d54f3
IEDL.DBID M48
ISSN 1857-9655
IngestDate Thu Aug 21 13:39:14 EDT 2025
Thu Jul 10 18:45:40 EDT 2025
Thu Jan 02 22:26:57 EST 2025
Thu Apr 24 23:09:19 EDT 2025
Sun Jul 06 05:02:49 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Keywords FISH
cystitis
IHC
carcinoma
urothelial bladder lesions
FGFR3
Language English
License http://creativecommons.org/licenses/by-nc/4.0
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3788-a3d4fe7b0729b4702a8d0549fa2ed952ccb1c471ba97a3ed1268bbd96ac6d54f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3889/oamjms.2017.048
PMID 28507621
PQID 1899408509
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5420767
proquest_miscellaneous_1899408509
pubmed_primary_28507621
crossref_primary_10_3889_oamjms_2017_048
crossref_citationtrail_10_3889_oamjms_2017_048
PublicationCentury 2000
PublicationDate 2017-04-15
PublicationDateYYYYMMDD 2017-04-15
PublicationDate_xml – month: 04
  year: 2017
  text: 2017-04-15
  day: 15
PublicationDecade 2010
PublicationPlace Macedonia
PublicationPlace_xml – name: Macedonia
– name: Republic of Macedonia
PublicationTitle Open access Macedonian journal of medical sciences
PublicationTitleAlternate Open Access Maced J Med Sci
PublicationYear 2017
Publisher ID Design 2012/DOOEL Skopje
Publisher_xml – name: ID Design 2012/DOOEL Skopje
References 31250
31261
31260
31245
31256
31244
31255
31247
31258
31246
31257
31241
31252
31240
31251
31243
31254
31242
31253
31249
31248
31259
24519156 - J Pathol. 2014 Jun;233(2):148-58
18231634 - Neoplasia. 2008 Jan;10(1):1-7
20542753 - Cancer Epidemiol. 2010 Dec;34(6):724-32
23657946 - Mol Cancer Ther. 2013 Jul;12(7):1245-54
11245416 - Cancer Res. 2001 Feb 15;61(4):1265-8
19243595 - J Exp Clin Cancer Res. 2009 Feb 25;28:27
19761767 - FEBS Lett. 2009 Oct 6;583(19):3254-8
26251520 - J Clin Pathol. 2015 Oct;68(10):819-24
18478569 - Int J Cancer. 2008 Aug 1;123(3):601-8
11679802 - Epidemiology. 2001 Nov;12(6):719-26
24898159 - Histopathology. 2015 Apr;66(5):639-49
22099989 - J Urol. 2012 Jan;187(1):310-4
22899908 - Adv Urol. 2012;2012:429213
24846059 - Cancer Med. 2014 Aug;3(4):835-44
2713858 - Cancer Res. 1989 May 15;49(10):2750-4
22890726 - Hepatology. 2013 Apr;57(4):1407-15
23705833 - Infect Agent Cancer. 2013 May 24;8(1):19
17668422 - J Pathol. 2007 Sep;213(1):91-8
25685453 - J Adv Res. 2013 Sep;4(5):461-6
18188671 - Cancer Causes Control. 2008 May;19(4):421-9
References_xml – ident: 31257
  doi: 10.1158/1535-7163.MCT-12-1150
– ident: 31243
– ident: 31261
  doi: 10.1111/his.12473
– ident: 31258
  doi: 10.1593/neo.07178
– ident: 31253
  doi: 10.1002/hep.25956
– ident: 31240
  doi: 10.1007/s10552-007-9104-7
– ident: 31247
  doi: 10.1002/cam4.262
– ident: 31259
  doi: 10.1136/jclinpath-2015-202898
– ident: 31249
  doi: 10.1016/j.febslet.2009.09.021
– ident: 31251
– ident: 31252
– ident: 31250
– ident: 31254
  doi: 10.1016/j.jare.2013.06.007
– ident: 31245
  doi: 10.1016/j.juro.2011.09.008
– ident: 31246
  doi: 10.1002/path.4334
– ident: 31248
  doi: 10.1002/path.2207
– ident: 31242
  doi: 10.1097/00001648-200111000-00022
– ident: 31256
  doi: 10.1002/ijc.23547
– ident: 31244
  doi: 10.1155/2012/429213
– ident: 31255
  doi: 10.1186/1756-9966-28-27
– ident: 31260
  doi: 10.1016/j.canep.2010.05.003
– ident: 31241
  doi: 10.1186/1750-9378-8-19
– reference: 22099989 - J Urol. 2012 Jan;187(1):310-4
– reference: 22890726 - Hepatology. 2013 Apr;57(4):1407-15
– reference: 24519156 - J Pathol. 2014 Jun;233(2):148-58
– reference: 20542753 - Cancer Epidemiol. 2010 Dec;34(6):724-32
– reference: 24846059 - Cancer Med. 2014 Aug;3(4):835-44
– reference: 18188671 - Cancer Causes Control. 2008 May;19(4):421-9
– reference: 26251520 - J Clin Pathol. 2015 Oct;68(10):819-24
– reference: 11679802 - Epidemiology. 2001 Nov;12(6):719-26
– reference: 23657946 - Mol Cancer Ther. 2013 Jul;12(7):1245-54
– reference: 23705833 - Infect Agent Cancer. 2013 May 24;8(1):19
– reference: 19761767 - FEBS Lett. 2009 Oct 6;583(19):3254-8
– reference: 18478569 - Int J Cancer. 2008 Aug 1;123(3):601-8
– reference: 18231634 - Neoplasia. 2008 Jan;10(1):1-7
– reference: 22899908 - Adv Urol. 2012;2012:429213
– reference: 11245416 - Cancer Res. 2001 Feb 15;61(4):1265-8
– reference: 25685453 - J Adv Res. 2013 Sep;4(5):461-6
– reference: 24898159 - Histopathology. 2015 Apr;66(5):639-49
– reference: 2713858 - Cancer Res. 1989 May 15;49(10):2750-4
– reference: 19243595 - J Exp Clin Cancer Res. 2009 Feb 25;28:27
– reference: 17668422 - J Pathol. 2007 Sep;213(1):91-8
SSID ssj0001596122
Score 2.0562387
Snippet BACKGROUND: Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and...
Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 160
SubjectTerms Basic Science
Title Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis
URI https://www.ncbi.nlm.nih.gov/pubmed/28507621
https://www.proquest.com/docview/1899408509
https://pubmed.ncbi.nlm.nih.gov/PMC5420767
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS-QwEA-egtyL-HXn-kUOfPCle9s0aZoHERVXOVTkzoI-laRJcWW31e0K-t8703ZXVz3wtZOkZfIxv-lMfkPIjhSORR0XeL6wzOMys3AO2swLXGaUCTRTpsryvQhPY_7nWly_lgNqFFh-6tphPal42G8_PTzvw4bfQ48zitTvQg_uBki97cs2LMhvZA7MksRdet5g_frKsAJrXkU_kf5IhULUVD-fjTFtpT5Az_cZlG9MUneRLDRYkh7Uk79EZly-TObPm2j5CukfPzVprjktMto96f4N6CUSM_RyqnNLkXOaHmBOedb8uqMgiYfVHV162MdTaUjPHI5QomicOkdHBf2XVlzFZTHo6bJXrpK4e3x1dOo11RW8FDnkPR1YnjlpkDrccNlhOrKA31SmmbNKsDQ1fgqmy2gldeCsz8LIGKtCnYZW8Cz4QWbzIndrhPoBdACJBWzDkQKMh4YrC1AkZVJ1ohZpj7WZpA31OFbA6CfggqD6k1r9Cao_AfW3yO6kw33NuvH_pr_G05PAzsBwh85d8VgmPriSyN_WUS3ys56uyWAMHoMZ8FtETk3kpAGybk9L8t5txb4tOIOucv0L790g3_EzMfjki00yOxo-ui3AMCOzDej9Jt6uVugLMnzzMQ
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+of+FGFR3+Protein+and+Gene+Amplification+in+Urinary+Bladder+Lesions+in+Relation+to+Schistosomiasis&rft.jtitle=Open+access+Macedonian+journal+of+medical+sciences&rft.au=Hammam%2C+Olfat&rft.au=Aboushousha%2C+Tarek&rft.au=El-Hindawi%2C+Ali&rft.au=Khairy%2C+Hosni&rft.date=2017-04-15&rft.issn=1857-9655&rft.eissn=1857-9655&rft.volume=5&rft.issue=2&rft.spage=160&rft_id=info:doi/10.3889%2Foamjms.2017.048&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1857-9655&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1857-9655&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1857-9655&client=summon